Craig Andrew Miller

Person

Mount Vernon, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted benzamides as RIPK2 inhibitors for treatment of inflamm...
- Patent number 12,139,484
- Issue date Nov 12, 2024
- Boehringer Ingelheim International GmbH
- Pingrong Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzamides as RIPK2 inhibitors
- Patent number 11,130,754
- Issue date Sep 28, 2021
- Boehringer Ingelheim International GmbH
- Pingrong Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzamides as RIPK2 inhibitors
- Patent number 10,138,241
- Issue date Nov 27, 2018
- Boehringer Ingelheim International GmbH
- Pingrong Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzamides as RIPK2 inhibitors
- Patent number 10,138,222
- Issue date Nov 27, 2018
- Boehringer Ingelheim International GmbH
- Jianwen Cui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, c...
- Patent number 8,859,814
- Issue date Oct 14, 2014
- Boehringer Ingelheim International GmbH
- Derek Cogan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
- Patent number 8,586,748
- Issue date Nov 19, 2013
- Boehringer Ingelheim International GmbH
- Asitha Abeywardane
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic...
- Patent number 8,575,360
- Issue date Nov 5, 2013
- Boehringer Ingelheim International GmbH
- Rene Marc Lemieux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxy...
- Patent number 8,552,205
- Issue date Oct 8, 2013
- Boehringer Ingelheim International GmbH
- Antonio Jose del Moral Barbosa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles...
- Patent number 7,790,712
- Issue date Sep 7, 2010
- Boehringer Ingelheim Pharmaceutical, Inc.
- Derek Cogan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cytokine heterocyclic compounds
- Patent number 7,514,458
- Issue date Apr 7, 2009
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Derek Cogan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cytokine heterocyclic compounds
- Patent number 7,214,802
- Issue date May 8, 2007
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Derek Cogan
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2
- Publication number 20250042901
- Publication date Feb 6, 2025
- Boehringer Ingelheim International GmbH
- Pingrong LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2
- Publication number 20220081437
- Publication date Mar 17, 2022
- Boehringer Ingelheim International GmbH
- Pingrong LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2
- Publication number 20190048000
- Publication date Feb 14, 2019
- Boehringer Ingelheim International GmbH
- Pingrong LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2
- Publication number 20180072717
- Publication date Mar 15, 2018
- Boehringer Ingelheim International GmbH
- Pingrong LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINE AND PYRAZINE COMPOUNDS AS INHIBITORS OF RIPK2
- Publication number 20180072703
- Publication date Mar 15, 2018
- Boehringer Ingelheim International GmbH
- Jianwen CUI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC...
- Publication number 20120252817
- Publication date Oct 4, 2012
- Boehringer Ingelheim International GmbH
- Rene Marc Lemieux
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-SULFONYLAMINO-4-HETEROARYL BUTYRAMIDE ANTAGONISTS OF CCR10
- Publication number 20110275800
- Publication date Nov 10, 2011
- Boehringer Ingelheim International GmbH
- Asitha Abeywardane
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA-SUBSTITUTED N-SULFONYL GYLCINE AMIDES ANTAGONISTS OF CCR10, C...
- Publication number 20110275612
- Publication date Nov 10, 2011
- Boehringer Ingelheim International GmbH
- Derek Cogan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXY...
- Publication number 20110224188
- Publication date Sep 15, 2011
- Boehringer Ingelheim International GmbH
- Antonio Jose del Moral Barbosa
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Cytokine Heterocyclic Compounds
- Publication number 20100190773
- Publication date Jul 29, 2010
- Boehringer Ingelheim International GmbH
- Asitha ABEYWARDANE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Cytokine Heterocyclic Compounds
- Publication number 20070142371
- Publication date Jun 21, 2007
- Derek Cogan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Cytokine Heterocyclic Compounds
- Publication number 20060276453
- Publication date Dec 7, 2006
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Daniel Goldberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Cytokine Heterocyclic Compounds
- Publication number 20060276496
- Publication date Dec 7, 2006
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Daniel Goldberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-cytokine heterocyclic compounds
- Publication number 20060079519
- Publication date Apr 13, 2006
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Derek Cogan
- C07 - ORGANIC CHEMISTRY

Craig Andrew Miller

Person

Patents Grantslast 30 patents

Substituted benzamides as RIPK2 inhibitors for treatment of inflamm...

Substituted benzamides as RIPK2 inhibitors

Substituted benzamides as RIPK2 inhibitors

Substituted benzamides as RIPK2 inhibitors

Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, c...

2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10

Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic...

Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxy...

Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles...

Anti-cytokine heterocyclic compounds

Anti-cytokine heterocyclic compounds

Patents Applicationslast 30 patents

HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2

HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2

HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2

HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2

PYRIDINE AND PYRAZINE COMPOUNDS AS INHIBITORS OF RIPK2

DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC...

2-SULFONYLAMINO-4-HETEROARYL BUTYRAMIDE ANTAGONISTS OF CCR10

ALPHA-SUBSTITUTED N-SULFONYL GYLCINE AMIDES ANTAGONISTS OF CCR10, C...

DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXY...

Anti-Cytokine Heterocyclic Compounds

Anti-Cytokine Heterocyclic Compounds

Anti-Cytokine Heterocyclic Compounds

Anti-Cytokine Heterocyclic Compounds

Anti-cytokine heterocyclic compounds